International Conference Genetically Modified Crops and Food in Europe – 10. December 2010, Riga GM Policy in Austria Aspects of Health and Environmental.

Slides:



Advertisements
Similar presentations
Precaution WTO Symposium, 6-7 July 2001 Current issues facing the World Trading System Session:Food Safety and SPS D. TAEYMANS, Director Scientific & Regulatory.
Advertisements

July 2002 EU Conference on 3Rs Animal Experimentation - a controversial issue.
Domestic Import Regulations for GMOs and their Compatibility with WTO Rules: Some Key Issues Heike Baumüller ICTSD Trade and Development Symposium
Accountability and Risk Governance - A Scenario-informed Reflection on European Regulation of GMOs Laura Drott Lukas Jochum.
SOURCE: “Co-existence project kicked-off”, European Biotechnology News, Vol. 4, 2005 European Commission project aimed at co- existence of GE and non-GE.
PPKE JÁK Budapest Jean Monnet Centre of Excellence Environmental Democracy Conference 19th October, 2012.
Regulation and Safety Assessment of Novel Foods in Canada William Yan, Ph.D. Office of Food Biotechnology Health Canada.
Genetically Modified Organisms Interactions with Population Health and Safety Chelsea Kadish Tyler Vaughn Ashley Wright.
Safety and Regulation in Agricultural Biotechnology MUPGRET Workshop.
Ministry of Agriculture of the Czech Republic Food Safety in the Czech Republic.
Agricultural Biotechnology Marshall A. Martin Professor and Associate Head Department of Agricultural Economics Purdue University March 2000.
BIOSAFETY CONCERNS IN THE CONTEXT OF BIOTECHNOLOGY. Presentation for Training Workshop for Regional Advisors Bangkok, Thailand May 2006.
FDA’s Policy for Evaluating Bioengineered Foods Jeanette Glover Glew Food and Drug Administration Center For Food Safety and Applied Nutrition September,
The Role of Biotechnology in a Sustainable Food Supply Section 3 : Risk Assessment Peggy G. Lemaux, University of California, Berkeley, California, U.S.A.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Abstract: In recent years, advances in genetic engineering and techniques of molecular biology have enabled the creation and commercial release of “Genetically.
GMO. What are GMOs? GMOs are plants or animals whose cells have been inserted with a gene from an unrelated species in order to take on specific characteristics.
Genetically engineered foods: a threat to human health? Encontro de Investigadores, Ciência 2009 Rita Batista.
Biosecurity Laws and Regulations in Turkey Prof. Dr. Hüseyin Avni Öktem Nanobiotechnology R&D Group, Department of Biological Sciences Middle East Technical.
GMOs and the WTO Rules Mark Halle Minsk, 24 October 2008.
“PRECAUTION AND THE REGULATION OF LIVING MODIFIED ORGANISMS (LMOs)” EMMA ISSATT.
Genetically Modified Organisms in Agricultural Production.
Risk assessment: Bt corn MON810 Risk assessment: identifying and evaluating possible dangers predicting the chances the danger will occur assessing the.
Biotech Food ‘safety and beyond’ Jeanine A. G. van de Wiel Health Council of the Netherlands Committee on Safety Assessment of Novel Foods
Regulatory Procedure for the Assessment of GM Foods.
Privacy Codes of Conduct as a self- regulatory approach to cope with restrictions on transborder data flow Dr. Anja Miedbrodt Exemplified with the help.
Training Session Product File Notes and Registration Reports, 23 October Registration Report: General aspects M. Trybou Federal Public Service of.
The History and Background of the Hungarian Moratorium Veronika Móra.
EU Regulatory framework on GMOs
Environmental and technology ethics Uncertainty, risk and precaution.
9 th ISBGMO, Jeju Island Korea Risk/Safety Assessment: Activities of the OECD Phil Macdonald Biotechnology Environmental Release Assessment Unit Canadian.
DIRECTORATE: GENETIC RESOURCES DEPARTMENT OF AGRICULTURE, FORESTRY AND FISHERIES 13 September 2013 G ENETICALLY MODIFIED ORGANISMS.
Seite GMO Policy in Austria (national strategy on cultivation and Co-existence, relevant legislation in Austrian Provinces ) by Heinz-Peter.
Briefing by Department of Health to joint meeting of the Portfolio Committees on Agriculture, Forestry and Fisheries, Health, Trade and Industry, Rural.
Geneticaly modified Food and Feed – current situation in EU Petr Beneš Food Safety Department Prague, 9 October 2009.
The environmental (in)coherance of European food policy Adrian Bebb Friends of the Earth Europe September 2006.
Introduction to GMOs: Myths and realities Masami Takeuchi, Ph.D. Food Safety Officer.
Kavala Workshop 1-2 June 2006 Legal protection of Transitional Waters [in the Cadses area]: A comparative analysis Dr. Petros Patronos / Dr. Liliana Maslarova.
Environmental Management System Definitions
ENVR 401 December 1, 2003 Supervisor: George McCourt Ashleigh Akalehiywot Andrea Hicks Mara Dacso Ted Walker Lillian Harris Kate Washington Regulation.
GM crops in the EU Campaigning opportunities and challenges FoEE and Greenpeace.
SOURCE: European Commission also adopted today three decisions on the placing on the.
Keller and Heckman LLP Market Access and Trade Barriers and Practices: The Role of the Precautionary Principle and Other Non-Scientific Factors in Regulating.
/ 1 International Workshop for CIS countries “ The use of standards for fresh fruit and vegetables and dry produce in technical regulations and the application.
The Principles Governing EU Environmental Law. 2 The importance of EU Environmental Law at the European and globallevel The importance of EU Environmental.
EU legislation on GMOs: Overview and challenges Euro Coop Sustainability Working Group 27 October 2010 Sébastien Goux Unit Biotechnologies.
Regulations and Ethics. There are two sides to every issue… Do I look like a Frankenfood?
What does it take to bring a GM crop to market? Alan McHughen UC Riverside
EU Plant Health Regime - Role of research -Evaluation of EU PLH Regime Guillermo H. Cardon European Commission, DG SANCO Plant health / Harmful organisms.
Abstract A step-wise or ‘tiered’ approach has been used as a rational procedure to conduct environmental risk assessments in many disciplines. The Technical.
EU legislation on GMOs: Overview and challenges Alberto Volpato, Counsellor for Health, Consumers, Agriculture Presented by Guy Van den Eede, Adviser for.
Genetically Modified Foods (GM or GMO foods). What is a Genetically Modified (GM) Food? Foods that contain an added gene sequence Foods that contain an.
What are GMOs? Some technical background on the genetic modification of plants Stuart Brown Associate Professor NYU School of Medicine.
GENETICALLY MODIFIED ORGANISM (GMO) TECHNOHOLICS.
1. Consumers, Health And Food Executive Agency European and international stakeholders Codex Alimentarius EU National implementations 2.
GM Plants and health issues - a subject of concern? Chandra Shekhar Misra “Plants for Life” International PhD Program – 2016 (course “Plant Biotechnology.
GENETICALLY MODIFIED ORGANISMS ACT
Plant Health Risk Assessment at EFSA
EFSA Trusted science for safe food Guilhem de Sèze
THE ETHICAL ISSUES THAT ARISE FROM THE PRODUCTION OF GMOs
WORKSHOP ON CULTURAL AND RELIGIOUS ISSUES SURROUNDING GMO’S
The EU and International Environmental Law
The EU‘s ‚participatory‘ authorisation process for GMOs
Business environment in the EU Prepared by Dr. Endre Domonkos (PhD)
Vytenis Andriukaitis European Commissioner for Health and Food Safety
How have humans been altering the gene pool of crops?
Health and Consumer Protection Sector: Biotechnology
ROLE OF KEPHIS IN SAFE HANDLING, TRANSFER AND USE OF GMOS.
Animal, Plant & Soil Science
Presentation transcript:

International Conference Genetically Modified Crops and Food in Europe – 10. December 2010, Riga GM Policy in Austria Aspects of Health and Environmental Risk Assessment taking into account the Precautionary Principle Dr. Michel Haas Federal Ministry of Health, Dep. II/B/15

Legal Basis -Directive 2001/18/EC on deliberate release implemented by Austrian Law on Genetechnology -Regulation 1829/2003 on GM food and feed Competent authority: Ministry of Health (GMO, GM Food) One Fundamental Principle in the Law on Gentechnology is the Precautionary Principle Since 1997 AT very critical in regard of approval of GMOs, strict policy of precaution

Austrian Bans on GMOs and main reasons 1997: BT- Maize 176 (Syngenta) -ARM gene with possible resistance against ampicillin -Possible unintended effects of BT Toxin on non target organisms -Possible resistance development in target pests 1999: Maize MON 810 -No assessment of indirect and long term effects of the BT – Toxin -Possible unintended effects on benign non target organisms -Possible resistance development in target pests

2000: Maize T 25 (herbicide resistant) -No integrated assessment of the combined effects of the GMO and the herbicide under realistic conditions 2004, 2006: EC fails to repeal the Austrian Bans 2006: Ban of oil seed rape GT 73 for import for all purposes -Toxicity not adequately assessed -Outcrossing and contamination of ruderal and conventional oil seed rape possible 2008: Bans on import of MON 810 and Maize T 25 for food and feed purposes lifted; Bans for import for cultivation are maintained

2008: Ban of oil seed rape Ms8xRf3 for similar reasons as for GT 73 Ban of maize MON 863 for import for all purposes -Tests on subchronic toxicity not state of the art -ARM Gene npt II problematic, possibility for transfer of antibiotic resistance against kanamycin, neomycin an other antibiotics not sufficiently assessed

Scientific dialogue with EFSA December 2008: Meeting AT Experts with the GMO Panel of EFSA on Maize MON 810 and T 25 April 2009: Meeting AT Experts with EFSA on MON 863, oil seed rape Ms8xRf3 and GT 73 No agreement on these Meeting with EFSA on scientific level December 2008 (ENVI Council): Council Conclusions -Environmental risk assessment to be improved -Scientific expertise must be strengthened

27 April 2010: AT Ban on Amflora Potato -Potential for transfer of the ARM Gene npt II not adequately addressed by EFSA GMO Panel -Environmental effects not sufficiently assessed -No adequate monitoring plan -Poor data qualitiy of the dossier Austrian Agency on Health and Food Security (AGES) mandated to explore the background resistance levels in Austria and possible ways of transfer of the ARM Gene to bacteria in soil and the gut.

Risk Assessment of GMOs in Austria - Federal Environmental Agency (UBA Wien) -Austrian Agency for Health and Food Security (AGES) Scrutinize GMO Dossiers of applicants within the harmonized Risk Assessment procedure (EFSA/ Member States)

Issues to be considered -Molecular characterization (stability and expression of insert, possible fusion proteins, ARM Genes, etc.) -Agricultural parameters (assessment of feld trials) -Nutritional composition (compared with isogene varieties), check of antinutrients -Allergenicity -Toxicity (tox. tests, feeding studies etc.)

Environmental Risk Assessment Assessment of possible long term effects on humans, animals and the environment -Effects of release on the receiving environment -Effects of possible gene transfer, outcrossing, spread of pollen etc. -Effects of interactions with other organisms GMO Unit of AGES elaborates combined assessment of the health and environmental risk aspects of the dossiers. Assessment is sent to EFSA by the Ministry of Health.

GMO risk assessment (Molecular Characterization/Food and Feed): General Approach (AGES) Focus of risk assessment concerning GMO dossiers according to regulation 1829/2003: 1. Data quality 2. Data presentation 3. Adherence to EFSA GMO risk assessment guidelines 4. Comparison of conventionally performed experiments with experimental design applied during GMO risk assessment

Major points of criticism raised by Austrian GMO risk assessors 1. EFSA GMO panel accepts insufficient data (e.g. inadequate sample number, number of generations etc… tested) 2. EFSA GMO panel accepts data which cannot be interpreted (e.g. wrong and/or diffuse banding pattern on Southern blots, broken gels, over/underexposed blots etc…) 3. EFSA GMO panel accepts insensitive detection methods which cannot provide the necessary sensitivity to allow sound conclusions (e.g. Southern blots with single restriction enzyme as evidence for genetic stability of the transgenic insert)

Conclusions of Austrian Food/Feed GMO risk assessors Data of poor quality (incomplete or otherwise not interpretable) presented by the notifier do not provide a sound basis for an adequate risk assessment. Due to flaws mentioned above the final EFSA opinion on the respective GMO suffers from a certain degree of uncertainty, which is proportional to the quality of the presented GMO dossier. Low quality dossiers result in EFSA opinions containing a high degree of uncertainty.

AT Position in the Regulatory Meetings So far mainly applications for GMOs with agricultural traits (herbicide resistance or insect resistance) in particular diverse GMO Maizelines, but also Soja, Cotton and Oil Seed Rape, have been put to vote in the Regulatory Committee of Directive 2001/18/EC or in SCFCAH and in the respective Meetings of the Environment and Agricultural Councils. As according to the AT assessment in all these cases data of risk assement reports provided by the notifyers lacked completeness and could not resolve questions of scientific uncertainty AT voted against an approval (due to the precautionary principle)

Role of the European Commission -So far no reactions in regard of the Austrian safeguard measures; bans are still in existence; -EC now working on Regulation for freedom for Member State to set up restrictions or bans for GMO Cultivation -AT wants reasons of environmental and health protection to be included -Socio-economic factors and reasons of public moral and public policy to be further explored.

Future Aspects AT experts also involved in the elaboration of Guidelines for the risk assessment for GMO Food and Feed and for the assessment of environmental effects of genetically modified plants. Contributions for improvement have been put forward and already been taken into account by the EC in her work to put these guidelines on a regulatory basis. AT Ministry of Health will further critically scrutinize relevant application dossiers. Work on amending Directive 2001/18/EC will be proactively tackled further under the Hungarian Presideny.

I thank you for your attention !